News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Pfizer Inc. (JOBS) Spun-Off Japan Lab, RaQualia Targets IPO by 2011
July 3, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO, July 3 (Reuters) - RaQualia, a pharma venture that was recently spun off by drug maker Pfizer Inc (PFE.N: Quote, Profile, Research, Stock Buzz), aims to go public by the first quarter of 2011, its president said on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
IPO
Startups
Asia
Pfizer
MORE ON THIS TOPIC
Mergers & acquisitions
J&J, Aiming for $50B in Cancer Sales, Buys Halda for $3B in Cash
November 17, 2025
·
2 min read
·
Dan Samorodnitsky
Collaboration
Lilly Bets More Than $2.6B for South Korea Biotech’s Bispecific Antibody Platform
November 17, 2025
·
2 min read
·
Tristan Manalac
Funding
Artios Pushes Cancer Pipeline Forward With $115M Series D
November 17, 2025
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
November 14, 2025
·
1 min read
·
Annalee Armstrong